NLSPW NLS PHARMACEUTICS LTD C/WTS 25/09/2025(TO PUR COM)
- 0.0101
- -0.0088-46.60%
NLS PHARMACEUTICS LTD C/WTS 25/09/2025(TO PUR COM) News
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
F-1: Registration statement for securities of certain foreign private issuers
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
D: Filing D
424B5: Prospectus
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
EFFECT: Others
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
CORRESP: CORRESP
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
UPLOAD: Others
Analysis
Price Target
No Data
No Data